VivoSeq
Other

Recovery

1

Pipeline Programs↗

12

Active Trials↗

12

Companies Involved↗

Recovery is an early-stage landscape with 1 program across 12 companies. The most active players are AstraZeneca, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Kazia Therapeutics Limited.

Intelligence

Pipeline Metrics

Competitive Density

31/100

Pipeline Velocity

27/100

Mech. Concentration

N/A

Completion Rate

84/100

Attrition Rate

12/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

AstraZeneca logo

AstraZeneca

0 programs

PreclinicalA

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

0 programs

PreclinicalK

Kazia Therapeutics Limited

0 programs

PreclinicalJ

JW Pharmaceutical

0 programs

PreclinicalOno Pharmaceutical Co. Ltd logo

Ono Pharmaceutical Co. Ltd

0 programs

PreclinicalC

Corcept Therapeutics

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical1

Dual NRT

Massachusetts General Hospital

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

69

clinical trials

Completed43 · 62%
Unknown status6 · 9%
Terminated5 · 7%
Not yet recruiting5 · 7%
Recruiting5 · 7%
Withdrawn3 · 4%
Other2 · 3%

Clinical Trials

Trial Activity

69 trials

Feasibility of Early Gabapentin as an Intervention for Neurorecovery
Recruiting·MMetroHealth Medical Center·Phase 4·NCT05302999·42 enrolled
Research on Clinical Recovery and Maintenance Strategies for CHB
Recruiting·—·N/A·NCT06803368·285 enrolled
Perioperative Argon Inhalation to Improve Neurocognitive Recovery After Carotid Surgery
Recruiting·NNegovsky Reanimatology Research Institute·Phase 3·NCT07200180·100 enrolled
Effect of Liberal and Restrictive IV Fluids on Recovery After Gallbladder Surgery
Recruiting·KKing Edward Medical University·Phase 1·NCT07488078·380 enrolled
Adjunctive Cannabidiol for Recovery From Opioid Study
Recruiting·IIcahn School of Medicine at Mount Sinai·Phase 3·NCT06940674·450 enrolled
To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects
Active, not recruiting·JJW Pharmaceutical·Phase 1·NCT07036458·8 enrolled
The Effect of a Bioactive Fabric Sleeve on Recovery in Division I Collegiate Baseball Players
Active, not recruiting·SStanford University·Preclinical·NCT06234202·13 enrolled
BXCL501 After Stress to Increase Recovery Success
Not yet recruiting·UUniversity of North Carolina, Chapel Hill·Phase 2·NCT06943404·100 enrolled
NAC for Hematopoietic Recovery in SAA
Not yet recruiting·PPeking University People's Hospital·Phase 2·NCT06518044·30 enrolled
Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019
Not yet recruiting·GGrünenthal GmbH·Phase 1·NCT07479745·10 enrolled
Pharmacodynamics & Pharmacokinetics Study of S-Acetyl Glutathione in Highly Trained Soccer Players
Not yet recruiting·UUniversity of Thessaly·Preclinical·NCT07690124·20 enrolled
Peer Recovery Coaching for Promoting Tobacco Abstinence in People With Opioid Use Disorder
Not yet recruiting·MMassachusetts General Hospital·Preclinical·NCT06965153·60 enrolled
Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-Acebilustat (CTX-4430)
Completed·CCeltaxsys, Inc.·Phase 1·NCT03964558·6 enrolled
A Study Investigating the Safety, Recovery, and Pharmacodynamics of Multiple Oral Administrations of SNIPR001 in Healthy Subjects
Completed·SSNIPR Biome Aps.·Phase 1·NCT05277350·36 enrolled
Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery
Completed·—·N/A·NCT01272583·16 enrolled
Page 1 of 5

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)